In retrospect, Cornerstone Macro analyst Carter Worth should not have called Coca-Cola (NYSE:KO) stock a post-earnings breakout candidate before it reported its results last Thursday. Coca-Cola stock, after rallying from its December lows, is more than a little bit in the red following
Buffington Mohr McNeal lowered its position in Morgan Stanley (NYSE:MS) by 2.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 105,514 shares of the financial services provider’s stock after selling 2,157 shares during the quarter. Morgan Stanley accounts for appro
BlackLine (NASDAQ:BL) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday.
According to Zacks, “BlackLine, Inc. is a provider of cloud-based solutions for Finance & Accounting which centralize and streamline financial close operations and other key F&A processes for midsize and large....More>>>
Check out the companies making headlines before the bell:
Xerox Xerox abandoned its planned $6.1 billion deal with Japan’s Fujifilm, in which Xerox would be combined with the Fuji Xerox joint venture. The move is part of a settlement with major investors Carl Icahn and Darwin Deason, who felt that Xerox was significantly undervalued in that deal. Fujifilm said it was considering its....More>>>
Teslas Current Financial Position and Near-Term Prospects
Teslas (NASDAQ: TSLA) weak balance sheet raises questions about its ability to meet financial obligations through March 31, 2018, which is when the company indicated Model 3 should reach full production levels of 5,000 units per week, and when many Seeking Alpha commenters expect Tesla to accelerate the Model 3 ramp.
Earlier this week, small capCell MedX Corp (OTCQB: CMXC) announced that it has completed its registration process with the FDA and has initiated an application process to receiveclearance for use of its eBalance device as Class II non-exempt device. Cell MedX Corpsebalance technology is designed to alleviatecomplications associated with certain medical conditions by reinvigorating the electrochemical....More>>>
Welcome. In this article I will give the dollar and cents reasons for how come ERIC looks like a relative bargain in today’s marketplace.
In the trailing ten years ERIC has earned their market cap in free cash flow. This is a signal the company may be undervalued. If ERIC can repeat the performance and earn over $19B in the coming....More>>>
On Wednesday, our Under the Radar Moversnewsletter suggestedsmall cap oncology stock Champions Oncology (NASDAQ: CSBR) as a buy for our short-term portfolio:
Normally we’d like for a new “turnaround” trade to be decisively above the 200-day moving average line (green) before pulling the trigger. We’re going to go ahead and step into Champions Oncology anyway, though,....More>>>
It was an unusual research project… Not one in 1,000 investment advisors or newsletter writers would ever consider it. My research partner and I read every shareholder letter issued by companies in the S&P 500 Index. I got the idea from billionaire superinvestor Warren Buffett. Several years ago, Buffett talked about a one-page fax he got from the CEO of a potential....More>>>
As it starts to downplay killer whale shows, SeaWorld said Tuesday that it hasn’t been drawing the same massive crowds to itsaquatic parks as it has in the past.
The shows featuring Shamu and the others might have inflamed with animal rights activists, but they have been a hit when it comes to filling stadiums. Throughout SeaWorld’s network of parks, attendance plunged 14.9% to....More>>>
Weddings can be both happy days for brides, grooms, and their families, and days filled with an enormous amount of stress.
In addition to any pre-marriage jitters, concerns over who’s upset about where he or she might be sitting, and worries that Uncle Jack may have a few too many at the reception, many marrying couples carry the burden of worrying about cost. Weddings can be expensive,....More>>>
Hilton Hotels (NYSE:HLT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Monday. The brokerage presently has a $90.00 price target on the stock. Zacks Investment Research‘s price objective would suggest a potent
There were six IPOs scheduled for this week (five yesterday and one today) with small cap Aquaventure Holdings LLC (NYSE: WAAS) appearing set to end the week with shares above their IPO debut price. AquaVenture Holdings is a global leader in water purification solutions and a pioneer in providi